Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs

In response to the unmet need for effective treatments for symptomatic patients, research efforts of inhaled therapy for COVID-19 patients have been pursued since the pandemic began. However, inhalation drug delivery to the lungs is sensitive to the lung anatomy and physiology, which can be signific...

Full description

Bibliographic Details
Main Authors: Jinxiang Xi, Brendan Walfield, Xiuhua April Si, Alexander A. Bankier
Format: Article
Language:English
Published: Ital Publication 2021-09-01
Series:SciMedicine Journal
Subjects:
Online Access:https://www.scimedjournal.org/index.php/SMJ/article/view/372
id doaj-85918bf1729942008c1a21a8d862c397
record_format Article
spelling doaj-85918bf1729942008c1a21a8d862c3972021-06-26T10:41:19ZengItal PublicationSciMedicine Journal2704-98332021-09-013319820810.28991/SciMedJ-2021-0303-188Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled LungsJinxiang Xi0Brendan Walfield1Xiuhua April Si2Alexander A. Bankier3Department of Biomedical Engineering, University of Massachusetts, Lowell, MA,Department of Biomedical Engineering, University of Massachusetts, Lowell, MA,Department of Aerospace, Industrial, and Mechanical Engineering, California Baptist University, Riverside, CA,3) Department of Radiology, University of Massachusetts Medical School, Worcester, MA, United States. 4) Department of Radiology, UMass Memorial Medical Center, Worcester, MA,In response to the unmet need for effective treatments for symptomatic patients, research efforts of inhaled therapy for COVID-19 patients have been pursued since the pandemic began. However, inhalation drug delivery to the lungs is sensitive to the lung anatomy and physiology, which can be significantly altered due to the viral infection. The ensued ventilation heterogeneity will change distribution and thus dosimetry of inhaled medications, rendering previous correlations concepts? of pulmonary drug delivery in healthy lungs less reliable. In this study, we first reviewed the recent developments of inhaled therapeutics and vaccines, as well as the latest knowledge of the lung structural variations documented by CT of COVID-19 patients' lungs. We then quantified the volume ratios of the poorly aerated lungs and non-aerated lungs in eight COVID-19 patients, which ranged 2-8% and 0.5-3%, respectively. The need to consider the diseased lung physiologies in estimating pulmonary delivery was emphasized. Diseased lung geometries with varying lesion sites and complexities were reconstructed using Statistical Shape Modeling (SSM). A new segmentation method was applied that could generate patient-specific lung geometries with an increased number of branching generations. The synergy of the CT-based lung segmentation and SSM-based airway variation showed promise for developing representative COVID-infected lung morphological models and investigating inhalation therapeutics in COVID-19 patients.   Doi: 10.28991/SciMedJ-2021-0303-1 Full Text: PDFhttps://www.scimedjournal.org/index.php/SMJ/article/view/372covid-19airway remodelinginhalation therapyinhaled vaccinebronchial constrictionstatistical shape modeling (ssm).
collection DOAJ
language English
format Article
sources DOAJ
author Jinxiang Xi
Brendan Walfield
Xiuhua April Si
Alexander A. Bankier
spellingShingle Jinxiang Xi
Brendan Walfield
Xiuhua April Si
Alexander A. Bankier
Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
SciMedicine Journal
covid-19
airway remodeling
inhalation therapy
inhaled vaccine
bronchial constriction
statistical shape modeling (ssm).
author_facet Jinxiang Xi
Brendan Walfield
Xiuhua April Si
Alexander A. Bankier
author_sort Jinxiang Xi
title Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
title_short Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
title_full Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
title_fullStr Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
title_full_unstemmed Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
title_sort lung physiological variations in covid-19 patients and inhalation therapy development for remodeled lungs
publisher Ital Publication
series SciMedicine Journal
issn 2704-9833
publishDate 2021-09-01
description In response to the unmet need for effective treatments for symptomatic patients, research efforts of inhaled therapy for COVID-19 patients have been pursued since the pandemic began. However, inhalation drug delivery to the lungs is sensitive to the lung anatomy and physiology, which can be significantly altered due to the viral infection. The ensued ventilation heterogeneity will change distribution and thus dosimetry of inhaled medications, rendering previous correlations concepts? of pulmonary drug delivery in healthy lungs less reliable. In this study, we first reviewed the recent developments of inhaled therapeutics and vaccines, as well as the latest knowledge of the lung structural variations documented by CT of COVID-19 patients' lungs. We then quantified the volume ratios of the poorly aerated lungs and non-aerated lungs in eight COVID-19 patients, which ranged 2-8% and 0.5-3%, respectively. The need to consider the diseased lung physiologies in estimating pulmonary delivery was emphasized. Diseased lung geometries with varying lesion sites and complexities were reconstructed using Statistical Shape Modeling (SSM). A new segmentation method was applied that could generate patient-specific lung geometries with an increased number of branching generations. The synergy of the CT-based lung segmentation and SSM-based airway variation showed promise for developing representative COVID-infected lung morphological models and investigating inhalation therapeutics in COVID-19 patients.   Doi: 10.28991/SciMedJ-2021-0303-1 Full Text: PDF
topic covid-19
airway remodeling
inhalation therapy
inhaled vaccine
bronchial constriction
statistical shape modeling (ssm).
url https://www.scimedjournal.org/index.php/SMJ/article/view/372
work_keys_str_mv AT jinxiangxi lungphysiologicalvariationsincovid19patientsandinhalationtherapydevelopmentforremodeledlungs
AT brendanwalfield lungphysiologicalvariationsincovid19patientsandinhalationtherapydevelopmentforremodeledlungs
AT xiuhuaaprilsi lungphysiologicalvariationsincovid19patientsandinhalationtherapydevelopmentforremodeledlungs
AT alexanderabankier lungphysiologicalvariationsincovid19patientsandinhalationtherapydevelopmentforremodeledlungs
_version_ 1721358887797391360